1 / 2

Center for Computational Molecular Phenotyping

Center for Computational Molecular Phenotyping. Principal Investigator: Robert E. Marc, PI Computational Molecular Phenotyping (CMP) is a set of technologies to visualize small molecules in cells

juliet
Télécharger la présentation

Center for Computational Molecular Phenotyping

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Center for Computational Molecular Phenotyping • Principal Investigator: Robert E. Marc, PI • Computational Molecular Phenotyping (CMP) is a set of technologies to visualize small molecules in cells • Small molecules form the cellular “metabolome” and “metabolomics” is the next frontier in molecular medicine • The Marc Laboratory possesses a large library of probes • The Marc Laboratory has three key technologies for commercialization: (1) CMP probe reagents to track small molecules(2) CMP microscope platforms to image molecules(3) CMP software for analyze molecular fingerprints • Potential IP includes probes applications,CMP platform component technologies, software applications, testing kits, and CMP systems for: medical diagnostics,drug discovery, forensics, environmental testing and agronomics screening.

  2. Center for Computational Molecular Phenotyping • MARKET OVERVIEW • Key small-scale  large-scale market & employment opportunities1-2 y : Neuroscience Research “Niche” $1.75 M/annum2-3 y : Cell Biology Research $2-10 M/annum4+ y : Medical diagnostics $10M-20 B/annum • Leading long-term market targetsChronic disease risk screeningOncology screening tools: molecular fingerprinting systemsNutrition monitoringDrug Discovery • Current distributors & licenseesSignature Immunologics (licensee and probe development)Chemicon, AbCAM, Cosmobio (distributors)

More Related